Washington, June 12 China is moving aggressively to dominate biotechnology and is already implementing many of the policies recommended by a US national security commission, raising concerns that Washington could lose its long-held leadership in a sector increasingly seen as critical to economic and military power.A new analysis released on Thursday by the National Security Commission on Emerging Biotechnology (NSCEB) said the Chinese Communist Party (CCP) is advancing biotechnology across five key areas identified in the commission's April 2025 action plan: national strategy, regulation, infrastructure, investment and data.The report argues that Beijing is moving faster than Washington in translating biotechnology…